Residual Tumor Volume and Tumor Progression after Subtotal Resection and Observation of WHO Grade I Skull Base Meningiomas
- PMID: 35832958
- PMCID: PMC9272298
- DOI: 10.1055/s-0041-1733974
Residual Tumor Volume and Tumor Progression after Subtotal Resection and Observation of WHO Grade I Skull Base Meningiomas
Abstract
Objective This study investigated the impact of residual tumor volume (RTV) on tumor progression after subtotal resection and observation of WHO grade I skull base meningiomas. Study Design This study is a retrospective volumetric analysis. Setting This study was conducted at a single institution. Participants Patients who underwent subtotal resection of a WHO grade I skull base meningioma and postsurgical observation (July 1, 2007-July 1, 2017). Main Outcome Measure The main outcome was radiographic tumor progression. Results Sixty patients with residual skull base meningiomas were analyzed. The median (interquartile range) RTV was 1.3 (5.3) cm 3 . Tumor progression occurred in 23 patients (38.3%) at a mean duration of 28.6 months postsurgery. The 1-, 3-, and 5-year actuarial progression-free survival (PFS) rates were 98.3, 58.6, and 48.7%, respectively. The Cox multivariate analysis identified increasing RTV ( p = 0.01) and history of more than 1 previous surgery ( p = 0.03) as independent predictors of tumor progression. In a Kaplan-Meier analysis for PFS, the RTV threshold of 3 cm 3 maximized log-rank testing significance between groups of patients dichotomized at 0.5 cm 3 thresholds ( p < 0.01). The 3-year actuarial PFS rates for meningiomas with RTV ≤3 cm 3 and >3 cm 3 were 76.2 and 32.1%, respectively. When RTV >3 cm 3 was entered as a covariate in the Cox model, it was the only factor independently associated with tumor progression ( p < 0.01). Conclusion RTV was associated with tumor progression after subtotal resection of WHO grade I skull base meningioma in this cohort. An RTV threshold of 3 cm 3 was identified that minimized progression of the residual tumor when gross total resection was not safe or feasible.
Keywords: meningioma; progression; recurrence; residual; skull base; tumor.
Thieme. All rights reserved.
Conflict of interest statement
Conflict of Interest A.S.L. is a consultant for SPIWay, LLC, and has an ownership interest in Kogent Surgical, LLC. The other authors declare no conflict of interest.
Figures
References
-
- Przybylowski C J, Hendricks B K, Frisoli F A et al. Prognostic value of the Simpson grading scale in modern meningioma surgery: Barrow Neurological Institute experience. J Neurosurg. 2020:1–9. - PubMed
-
- Nanda A, Bir S C, Maiti T K, Konar S K, Missios S, Guthikonda B. Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization grade I meningioma. J Neurosurg. 2017;126(01):201–211. - PubMed
-
- Winther T L, Torp S H. Significance of the extent of resection in modern neurosurgical practice of World Health Organization grade I meningiomas. World Neurosurg. 2017;99:104–110. - PubMed
-
- Materi J, Mampre D, Ehresman J, Rincon-Torroella J, Chaichana K L. Predictors of recurrence and high growth rate of residual meningiomas after subtotal resection. J Neurosurg. 2020:1–7. - PubMed
-
- Youngblood M W, Duran D, Montejo J D et al. Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg. 2019:1–10. - PubMed
